INS and type 2 diabetes mellitus: After suppression of HNF1A, we observed defects in insulin and glucagon secretion reminiscent of phenotypes in humans with HNF1A deficiency, including patients with HNF1A-MODY (13, 14) and those with T2D (4, 32).